Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277510 · ClinicalTrials.gov registry record · Phase 3
Pediatric Chronic Kidney Disease Safety and Efficacy
A Phase 3 study, sponsored by Amgen.
- Terminated
- Registry status
- Phase 3
- Development phase
- 43
- Enrollment target
NCT01277510 is a Phase 3 study that was terminated before completion, run by Amgen. The registered enrollment target is 43 participants.
The verdict
NCT01277510, a Phase 3 study, was terminated before completion, sponsored by Amgen.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of adding cinacalcet to the current treatment of secondary hyperparathyroidism in children currently receiving dialysis compared to a treatment regimen that does not include cinacalcet.
Interventions
- DRUG placebo
- DRUG Standard of Care
- DRUG cinacalcet capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-06-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01277510
The ClinicalTrials.gov registry entry for NCT01277510 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01277510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01277510 about?
NCT01277510 is a clinical study titled "Pediatric Chronic Kidney Disease Safety and Efficacy". The purpose of this study is to assess the safety and efficacy of adding cinacalcet to the current treatment of secondary hyperparathyroidism in children currently receiving dialysis compared to a treatment regimen that does not include cinacalcet.
What is the current status of trial NCT01277510?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 43 participants. The study started on 2011-06-28.
What interventions are being tested in trial NCT01277510?
The interventions under investigation include: placebo (DRUG), Standard of Care (DRUG), cinacalcet capsule (DRUG).
Who is sponsoring clinical trial NCT01277510?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.